Fresenius Medical Care AG

BIT:1FME Stock Report

Market Cap: €13.2b

Fresenius Medical Care Ownership

Who are the major shareholders and have insiders been buying or selling?


Recent Insider Transactions

Insider Trading Volume

Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.


Ownership Breakdown

What is the ownership structure of 1FME?
Owner TypeNumber of SharesOwnership Percentage
Private Companies58,1730.0198%
Individual Insiders62,8560.0214%
General Public75,801,11925.8%
Public Companies94,380,38232.2%
Institutions123,110,91942%

Dilution of Shares: Shareholders have not been meaningfully diluted in the past year.


Top Shareholders

Top 25 shareholders own 68.43% of the company
OwnershipNameSharesCurrent ValueChange %Portfolio %
32.2%
Fresenius SE & Co. KGaA
94,380,382€4.3b0%no data
7.49%
Dodge & Cox
21,985,617€990.7m-0.11%0.34%
4.95%
Harris Associates L.P.
14,526,582€654.6m-4.26%0.8%
4.34%
BlackRock, Inc.
12,738,437€574.0m39.8%0.01%
4.25%
Pzena Investment Management, Inc.
12,480,509€562.4m0.13%1.08%
2.81%
The Vanguard Group, Inc.
8,240,316€371.3m0.05%0.01%
2.21%
Artisan Partners Limited Partnership
6,480,973€292.0m0%0.23%
2%
Fiduciary Management, Inc.
5,867,592€264.4m24.3%1.85%
1.16%
Fidelity International Ltd
3,405,809€153.5m0%0.07%
0.96%
Lazard Asset Management LLC
2,817,730€127.0m2.51%0.12%
0.81%
Dimensional Fund Advisors LP
2,362,437€106.5m0.97%0.02%
0.66%
Deka Investment GmbH
1,944,436€87.6m-14.9%0.08%
0.6%
Geode Capital Management, LLC
1,761,699€79.4m0.07%0.01%
0.57%
Columbia Management Investment Advisers, LLC
1,678,583€75.6m2.5%0.02%
0.44%
Norges Bank Investment Management
1,278,560€57.6m0%no data
0.43%
Amundi Asset Management SAS
1,266,990€57.1m6.78%0.01%
0.39%
SEI Investments Management Corporation
1,158,081€52.2m-5.99%0.1%
0.39%
Charles Schwab Investment Management, Inc.
1,140,823€51.4m1.27%0.01%
0.32%
Baillie Gifford & Co.
951,352€42.9m-0.79%0.02%
0.29%
Invesco Ltd.
846,347€38.1m0.31%0.01%
0.25%
M&G Investment Management Limited
726,383€32.7m0%0.07%
0.24%
Deutsche Asset & Wealth Management
695,601€31.3m-0.03%0.01%
0.23%
UBS Asset Management AG
687,903€31.0m15.7%no data
0.23%
Eurizon Capital S.A.
680,519€30.7m0%0.22%
0.23%
Allianz Asset Management GmbH
666,736€30.0m0%0.01%

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2024/12/18 15:51
End of Day Share Price 2024/12/18 00:00
Earnings2024/09/30
Annual Earnings2023/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .

Analyst Sources

Fresenius Medical Care AG is covered by 59 analysts. 18 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Martin SchneeAlphaValue
Brian WilliamsAvondale Partners
Olav ZilianBaader Helvea Equity Research